(Q43455943)

English

Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center

scientific article published on 5 August 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

phase I clinical trial

0 references

Razelle Kurzrock

10

object named as

Razelle Kurzrock

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ignacio Garrido-Laguna

1

object named as

Ignacio Garrido-Laguna

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Apostolia Maria Tsimberidou

8

object named as

Apostolia M Tsimberidou

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

7

object named as

Aung Naing

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

2

object named as

Filip Janku

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Christos Vaklavas

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Gerald S Falchook

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Siqing Fu

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

David S Hong

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sijin Wen

9

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

5 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1422-1428

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Prospective validation of a prognostic score to improve patient selection for oncology phase I trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Inhibition of the hedgehog pathway in advanced basal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

21 January 2018

Risks and benefits of phase 1 oncology trials, revisited

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

7 January 2021

based on heuristic

inferred from DOI database lookup

90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26413

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.26413

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43455943&oldid=1989176750"